# Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix

> **NCT03202381** · PHASE4 · UNKNOWN · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 35 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Degarelix

## Key facts

- **NCT ID:** NCT03202381
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-26
- **Primary completion:** 2019-03
- **Final completion:** 2020-03
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2017-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03202381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03202381, "Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03202381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*